Heart Disease Trial, Recruiting NCT07427472 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07427472
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a hereditary condition called heterozygous familial hypercholesterolaemia (a genetic condition that causes high cholesterol levels)
  • People aged between 30 and 60 years old
  • People who had both a coronary calcium score scan and a coronary CT angiogram (detailed heart imaging scans) at least 5 years ago, and both scans were done exclusively at the same imaging centre (ICT de la Pitié Salpêtrière)
  • People who had no chest pain during physical activity at the time of their earlier heart scan
  • People who have had a clinical examination performed
  • People who are covered by a social protection or health insurance scheme (excluding AME)
  • People who have been informed about the trial and have signed a consent form

Who may not be able to join:

  • People who are under guardianship or who are unable to give consent
  • People who are pregnant or breastfeeding
  • People who weigh more than 250 kg (due to technical limitations of the scanning equipment)
  • People who are currently taking part in another clinical research study involving the human body, or who are still within an exclusion period following a previous research study
  • People who are subject to a legal protection order
  • People who have a medical reason why they cannot take the medications esmolol and/or atenolol (heart rate-lowering medicines used during scanning)
  • For people who need to have a new CT angiogram and a chest-abdomen-pelvis CT scan, additional criteria apply — people with reduced kidney function, poorly controlled diabetes at the time of a previous heart scan, a personal history of heart disease or heart attack at the time of their earlier scan, a medical reason preventing the use of iodine-based contrast dye, or people who previously had an adverse reaction during an earlier heart CT scan, may not be eligible (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 33(0)1 42 17 57 74

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 June 2026
Est. completion
19 June 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Progression of coronary artery disease over 5 years in patients with heterozygous familial hypercholesterolemia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov